
EU GMP Annex 22: AI Pulse Check panelists say most manufacturers aren’t ready, static AI models likely stay central, and local AI deployment grows.
-Micronization improves API bioavailability in new chemical entities. -Increased market demand for micronization has sparked increased CMO services. -Lonza Engine™ provides advantages throughout the drug development process.





